These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4359798)

  • 1. Poliovirus antibody in urban school children.
    Linnemann CC; Stefanovic G; Shea L; May DB; Schiff GM
    J Pediatr; 1974 Mar; 84(3):404-6. PubMed ID: 4359798
    [No Abstract]   [Full Text] [Related]  

  • 2. Poliovirus antibody differentiation. Methods and application for strain specific diagnosis in complications after oral vaccination.
    Kuwert E; Höher PG; Thraenhart O
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):407-12. PubMed ID: 180727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Poliomyelitis immunity status in the centro-meridional Italy].
    Ribera G; Angelillo IF; Ricciardi G; Grasso GM; Villari P
    Ann Ig; 1995; 7(6):421-9. PubMed ID: 8663971
    [No Abstract]   [Full Text] [Related]  

  • 4. Poliovirus antibody status after vaccination with trivalent oral vaccine.
    Clara R; Deprettere A; van der Berghe D; Pattyn S
    Acta Paediatr Belg; 1976; 29(4):245-51. PubMed ID: 192040
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Parameters (r-value of the immunity status, cumulative vaccination participation, index of the relative vaccination participation) for the surveillance of poliomyelitis in a city of the Ruhr-area].
    Höher PG; Thraenhart O; Kuwert E; Bohlmann HG; Worringen W; Lagarie GW
    Zentralbl Bakteriol Orig B; 1973 Feb; 156(6):471-85. PubMed ID: 4713086
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody to poliovirus in older children and young adults in Israel and the use of poliovaccines for the immunization of the seronegatives.
    Goldblum N; Kra-Oz Z; Swartz T
    Dev Biol Stand; 1979; 43():173-7. PubMed ID: 230108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antibody to poliovirus in patients in a mental deficiency hospital, with particular reference to Down's syndrome.
    McKay E; Hems G; Massie A; Moffat MA; Phillips KM
    J Hyg (Lond); 1978 Aug; 81(1):25-30. PubMed ID: 211162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neutralizing antibodies in the sera of persons vaccinated with intradermal poliovirus vaccine].
    Jarzabek Z; Kańtoch M
    Przegl Epidemiol; 1984; 38(3):323-6. PubMed ID: 6098935
    [No Abstract]   [Full Text] [Related]  

  • 10. Poliovirus antibodies in age groups: an assessment of obligatory vaccination in Belgium.
    Lamy ME; Cornu C; Desmyter J
    Dev Biol Stand; 1979; 43():207-13. PubMed ID: 230111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing capacity of poliovirus type 3 antibodies tested against 5 different intratypic variants of poliovirus type 3. A comparative study in children immunized with live, inactivated, or both types of poliovirus vaccines.
    Böttiger M
    Arch Gesamte Virusforsch; 1971; 35(2):251-5. PubMed ID: 4332939
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stage of immunity to Poliovirus type 1 and 3 in adult women and in newborn infants: study of comparative efficiency of 2 methods for determination of neutralizing antibodies].
    Barbi M
    Ann Sclavo; 1972; 14(6):694-704. PubMed ID: 4360238
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of poliovirus neutralizing antibodies in young adult women.
    Mayer TR; Balfour HH
    JAMA; 1981 Sep; 246(11):1207-9. PubMed ID: 6267329
    [No Abstract]   [Full Text] [Related]  

  • 14. Modified radial-plaque-neutralization test for demonstration of enterovirus neutralizing antibodies.
    Nagy G; Takátsy S
    Arch Virol; 1980; 65(2):89-98. PubMed ID: 6252870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroimmunity to polioviruses in an urban population of Italy.
    Volpi A; Ragona G; Biondi W; Rocchi G; Archetti I
    Bull World Health Organ; 1976; 54(3):275-8. PubMed ID: 191208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response of children immunized with poliovaccines: an evaluation using two strains of poliovirus type 1.
    Deshpande JM; Dave KH
    Indian J Med Res; 1992 Sep; 95():216-20. PubMed ID: 1335965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of poliovirus neutralizing antibodies eight years after immunization with live, attenuated-virus vaccine.
    Rousseau WE; Noble GR; Tegtmeier GE; Jordan MC; Chin TD
    N Engl J Med; 1973 Dec; 289(25):1357-9. PubMed ID: 4356637
    [No Abstract]   [Full Text] [Related]  

  • 18. [Paralytic poliomyelitis and poliomyelitis-like diseases in children].
    Leschinskaia EV; Ashmarina EE; Martynenko IN; Andreeva LS; Gracheva LA
    Pediatriia; 1979 Dec; (12):13-7. PubMed ID: 230451
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference.
    John TJ; Jayabal P
    Am J Epidemiol; 1972 Oct; 96(4):263-9. PubMed ID: 4342327
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of neutralizing antibody responses against poliovirus types 1, 2 and 3 in the Tripoli area of the Socialist People's Libyan Arab Jamahiriya.
    el Nageh M; Khadre MA; Gould EA
    Trans R Soc Trop Med Hyg; 1988; 82(5):758-60. PubMed ID: 2855283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.